Company Filing History:
Years Active: 2005
Title: Greg Angus McIntosh: Innovator in Hemoglobin-Antioxidant Conjugates
Introduction
Greg Angus McIntosh is a notable inventor based in Scarborough, Canada. He has made significant contributions to the field of biocompatible chemical compositions, particularly in the development of hemoglobin-antioxidant conjugates. His work focuses on creating compositions that protect mammalian bodies from oxidative damage.
Latest Patents
McIntosh holds a patent for "Hemoglobin-antioxidant conjugates." This invention provides biocompatible chemical compositions that possess oxygen transporting capabilities. These compositions consist of oxygen transporting molecules that are chemically bound to antioxidants. An example of this composition is hemoglobin covalently coupled to a 6-hydroxy chroman carboxylic acid, such as Trolox. This innovative approach aims to enhance the protective effects against oxidative damage in living organisms.
Career Highlights
Throughout his career, McIntosh has worked with several prominent companies in the biotechnology sector. Notable among these are Hemosol Inc. and Therapure Biopharma Inc. His experience in these organizations has contributed to his expertise in developing advanced biocompatible solutions.
Collaborations
Some of McIntosh's coworkers include James Gordon Adamson. Their collaborative efforts have likely played a role in advancing the research and development of innovative biocompatible compositions.
Conclusion
Greg Angus McIntosh is a distinguished inventor whose work in hemoglobin-antioxidant conjugates has the potential to significantly impact the field of biocompatible chemical compositions. His contributions reflect a commitment to enhancing health through innovative solutions.